Amanote Research
Register
Sign In
Weiterbehandlung Mit Pemetrexed Nach First-Line Pemetrexed/Cisplatin
Best Practice Onkologie
- Germany
doi 10.1007/bf03359830
Full Text
Open PDF
Abstract
Available in
full text
Categories
Oncology
Date
August 1, 2011
Authors
Unknown
Publisher
Springer Science and Business Media LLC
Related search
P3.17-22 Nivolumab Plus Cisplatin/Pemetrexed or Cisplatin/Gemcitabine as Induction in Resectable NSCLC
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Pemetrexed Induced Life-Threatening Anaphylaxis
Cureus
Adjuvant Bidirectional Chemotherapy With Intraperitoneal Pemetrexed Combined With Intravenous Cisplatin for Diffuse Malignant Peritoneal Mesothelioma
Gastroenterology Research and Practice
Hepatology
Gastroenterology
P3.01-47 Clinical Characteristics and Outcome for Patients With Advanced Lung Adenocarcinoma Treated With First-Line Pemetrexed Plus Platinum
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
In Vitro Characterization of Cisplatin and Pemetrexed Effects in Malignant Pleural Mesothelioma 3D Culture Phenotypes
Cancers
Cancer Research
Oncology
P3.01-94 Safety and Efficacy of First-Line Pemetrexed Versus Bevacizumab-Containing Regimens in Advanced Non-Small Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P1.01-65 PII of Pemetrexed or Pemetrexed Plus Bevacizumab for Previously Untreated Elderly (>=75) Non-Squamous NSCLC (LOGIK1201)
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
MA12.05 Phase 1 Study of HSP90 Inhibitor Ganetespib With Pemetrexed and Cisplatin/Carboplatin Chemotherapy for Pleural Mesothelioma
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Long Progression-Free Survival by Pemetrexed Continuation Maintenance Therapy Following Cisplatin-Based Chemotherapy in Malignant Pleural Mesothelioma
Internal Medicine
Internal Medicine
Medicine
